{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:43:35Z","timestamp":1792651415539,"version":"4.5.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T00:00:00Z","timestamp":1356048000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0050447","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T01:46:14Z","timestamp":1356140774000},"page":"e50447","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Optimising Immunogenicity with Viral Vectors: Mixing MVA and HAdV-5 Expressing the Mycobacterial Antigen Ag85A in a Single Injection"],"prefix":"10.1371","volume":"7","author":[{"given":"Gareth","family":"Betts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Poyntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Reyes-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cottingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,21]]},"reference":[{"key":"ref1","unstructured":"StopTBpartnership (2011) (<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.stoptb.org\/resources\/factsheets\/fastfacts.asp\" xlink:type=\"simple\">http:\/\/www.stoptb.org\/resources\/factsheets\/fastfacts.asp<\/ext-link>) Stop TB partnership website.Accessed 2012 Nov 25."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"LC Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2010.09.015","article-title":"Future vaccination strategies against tuberculosis: thinking outside the box","volume":"33","author":"SH Kaufmann","year":"2010","journal-title":"Immunity"},{"key":"ref4","first-page":"156","article-title":"Vaccine strategies against tuberculosis","volume":"139","author":"H McShane","year":"2009","journal-title":"Swiss Med Wkly"},{"key":"ref5","first-page":"200","article-title":"Tuberculosis in the HIV-positive patient","volume":"56","author":"EL Corbett","year":"1996","journal-title":"Br J Hosp Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.4049\/jimmunol.162.9.5407","article-title":"Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis","volume":"162","author":"AM Caruso","year":"1999","journal-title":"J Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1073\/pnas.97.8.4204","article-title":"Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice","volume":"97","author":"AO Sousa","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(04)17552-1","article-title":"Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies","volume":"364","author":"SE Dorman","year":"2004","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"JL Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","article-title":"Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management","volume":"3","author":"MA Gardam","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"PA Darrah","year":"2007","journal-title":"Nat Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/eji.200737504","article-title":"Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations","volume":"37","author":"NE Beveridge","year":"2007","journal-title":"Eur J Immunol"},{"key":"ref13","unstructured":"clinicaltrials.gov (website) (<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00953927?cntry1=AF%3AZA&phase=1&rank=136\" xlink:type=\"simple\">http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00953927?cntry1=AF%3AZA&amp;phase=1&amp;rank=136<\/ext-link>) Clinical trials website.Accessed 2012 Nov 25."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"NP Goonetilleke","year":"2003","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"FA Verreck","year":"2009","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"HM Vordermeier","year":"2009","journal-title":"Infect Immun"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"H McShane","year":"2004","journal-title":"Nat Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"MJ McElrath","year":"2008","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2240","article-title":"Viruses as vaccine vectors for infectious diseases and cancer","volume":"8","author":"SJ Draper","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.4049\/jimmunol.181.7.4955","article-title":"Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice","volume":"181","author":"EK Forbes","year":"2008","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"M Santosuosso","year":"2006","journal-title":"Infect Immun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","article-title":"The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults","volume":"181","author":"B Abel","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0264-410X(01)00450-9","article-title":"Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes","volume":"20","author":"SC Gilbert","year":"2002","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4161\/hv.6.1.10116","article-title":"Prime-boost vectored malaria vaccines: progress and prospects","volume":"6","author":"AV Hill","year":"2010","journal-title":"Hum Vaccin"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/IAI.00740-09","article-title":"Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses","volume":"78","author":"A Reyes-Sandoval","year":"2010","journal-title":"Infect Immun"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/eji.200737672","article-title":"Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei","volume":"38","author":"A Reyes-Sandoval","year":"2008","journal-title":"Eur J Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/IAI.70.3.1623-1626.2002","article-title":"Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A","volume":"70","author":"H McShane","year":"2002","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nm0498-397","article-title":"Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara","volume":"4","author":"J Schneider","year":"1998","journal-title":"Nat Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/mt.2008.141","article-title":"The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens","volume":"16","author":"R Schirmbeck","year":"2008","journal-title":"Mol Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1128\/JVI.00427-06","article-title":"Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB\/c mice","volume":"80","author":"DC Tscharke","year":"2006","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0506768102","article-title":"HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation","volume":"102","author":"C Oseroff","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","article-title":"SPICE: Exploration and analysis of post-cytometric complex multivariate datasets","author":"M Roederer","year":"2011","journal-title":"Cytometry A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1128\/JVI.02497-06","article-title":"Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors","volume":"81","author":"K McCoy","year":"2007","journal-title":"J Virol"},{"key":"ref34","article-title":"Mixed Vector Immunization With Recombinant Adenovirus and MVA Can Improve Vaccine Efficacy While Decreasing Antivector Immunity","volume":"Feb 21","author":"A Reyes-Sandoval","year":"2012","journal-title":"Mol Ther"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0050447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T03:38:58Z","timestamp":1687923538000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0050447"}},"subtitle":[],"editor":[{"given":"Paulo Lee","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,21]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0050447","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,21]]}}}